Cetrelimab (Anti-PDCD1 / PD-1 / CD279)

Cetrelimab (Anti-PDCD1 / PD-1 / CD279) is a humanized monoclonal antibody targeting programmed cell death 1 (PD-1). It inhibits tumor growth in vivo. MW :145.04 KD.
Supplier Selleck Chemicals
Product # A3029
Sku # A3029-1mg*25
Pricing 1mg*25, $2970.00
Feedback